This concept is supported by the observation that a large proportion of TTF-1-positive colonic or gastric cancers also showed an immunohistochemical expression of at least one of the following markers: SATB2, CK20, FABP1, and Villin-1. The gene discussed is SATB2; the disease is gastric cancer.